Home » Topics » BioWorld Science

BioWorld Science
RSS

MEI Pharma initiates phase II study of ME-401 in follicular lymphoma

Dec. 27, 2018

Shenzhen Salubris Pharmaceuticals describes DPP-IV inhibitors for diabetes

Dec. 27, 2018

NantBioScience reports high-affinity nerve growth factor receptor inhibitors

Dec. 27, 2018

Oryzon patents lysine-specific demethylase inhibitors

Dec. 27, 2018

New LAG-3 ligand identified

Dec. 27, 2018

ASO for LCA

Dec. 27, 2018

Tumor-targeted trimeric 4-1BB-agonistic antibody 1D8N/CEGa1 shows safety and efficacy in vivo

Dec. 27, 2018

Novel CD38 CAR cell therapy for the treatment of multiple myeloma

Dec. 27, 2018

Alnylam Pharmaceuticals develops siRNA targeting the thrombopoietin gene in the liver

Dec. 27, 2018

Momenta initiates phase II trial of M-281 in generalized myasthenia gravis

Dec. 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...